AmerisourceBergen Corp. (ABC)

AmerisourceBergen Corporation, a pharmaceutical services company, offers drug distribution and related services to healthcare providers and pharmaceutical manufacturers in the United States, the United Kingdom, and Canada. It distributes brand name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers, such as acute care hospitals and health systems, independent and chain retail pharmacies, mail order facilities, physicians, medical clinics, and long-term care and other alternate site pharmacies. The company also provides pharmacy management, staffing and other consulting services, scalable automated pharmacy dispensing equipment, medication and supply dispensing cabinets, and supply management software to retail and institutional healthcare providers. In addition, it offers distribution and other services to physicians, who specialize in various disease states; distributes vaccines, injectibles, and plasma and other blood products; and provides commercialization services, third party logistics, group purchasing services, and other services for biotech and other pharmaceutical manufacturers, as well as reimbursement consulting, data analytics, practice management, and physician education. Further, AmerisourceBergen delivers unit dose, punch card, unit-of-use, and compliance and other packaging solutions to institutional and retail healthcare providers; and offers contract packaging and clinical trial materials services for pharmaceutical manufacturers. It serves customers through a network of distribution and service centers, and packaging facilities. The company was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.

For the fiscal year ended 30 September 2006, AmerisourceBergen Corp.'s revenues increased 12% to $61.2B. Net income from continuing operation before accounting change increased 60% to $468M. Revenues reflect improved performance from Pharmaceutical Distribution, specialty business and PharMerica segment. Net income also reflects the absence of loss on early retirement of debt and decreased interest expense.